About Dr. Fogelman

Amy G. Fogelman, MD is Board Certified in Internal Medicine with over 15 years of experience seeing patients at Harvard-affiliated practices in the Boston area. She has also held a faculty appointment at Harvard Medical School. Dr. Fogelman has been awarded prizes in clinical excellence and leadership at Massachusetts General Hospital (MGH).

Dr. Fogelman graduated with a BA in Biology from Wesleyan University in Connecticut and went on to receive her MD from Boston University School of Medicine. She completed her Internship and Residency at Beth Israel Deaconess Medical Center in Boston and a Chief Residency in Primary Care at the Veterans Affairs Hospital in West Roxbury, as well as a fellowship in Primary Care at MGH in Boston.

Dr. Fogelman has particular expertise in opioid prescribing policies. She led a multi-disciplinary group to create a first-of-its-kind hospital-wide Primary Care pain policy at MGH as chair of the Opioid Task Force. More recently she served as a member of the Opioid Safety Group at Beth Israel Deaconess Healthcare, overseeing their Primary Care pain policy. As a consultant, she has reviewed a Major Health System’s clinicians’ opioid prescribing. Dr. Fogelman was a designated member of the Special Commission to Study Medication-Assisted Treatment for Opioid Use Disorder in the Commonwealth of Massachusetts.

Dr. Fogelman is a career-long educator who can communicate to medical students, residents, patients, and jury members about complex medical issues in easy to understand terms.  She is currently serving as a member of the Massachusetts Medical Society’s House of Delegates and Committee on Ethics, Grievances and Professional Standards. She sees patients at Fenway Health in Boston.